malondialdehyde has been researched along with lacosamide in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 1 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Aksoy, D; Erbas, O; Eser, E; Solmaz, V; Yılmaz, M | 1 |
| Nirwan, N; Siraj, F; Vohora, D | 1 |
| Bilal, B; Erbas, O; Erdogan, MA; Kirazlar, M; Yigitturk, G | 1 |
3 other study(ies) available for malondialdehyde and lacosamide
| Article | Year |
|---|---|
Demonstration of ameliorative effect of lacosamide: in a rat model of sepsis-induced critical illness polyneuropathy.
Topics: Acetamides; Animals; Anti-Inflammatory Agents; C-Reactive Protein; Disease Models, Animal; Lacosamide; Leukocytes; Lipid Peroxidation; Male; Malondialdehyde; Muscle, Skeletal; Polyneuropathies; Rats; Rats, Sprague-Dawley; Sepsis; Tumor Necrosis Factor-alpha | 2015 |
Inverted-U response of lacosamide on pilocarpine-induced status epilepticus and oxidative stress in C57BL/6 mice is independent of hippocampal collapsin response mediator protein-2.
Topics: Animals; Anticonvulsants; Disease Models, Animal; Dose-Response Relationship, Drug; Exploratory Behavior; Glutathione; Hippocampus; Intercellular Signaling Peptides and Proteins; Lacosamide; Lipid Peroxidation; Male; Malondialdehyde; Mice; Mice, Inbred C57BL; Motor Activity; Muscarinic Agonists; Nerve Tissue Proteins; Oxidative Stress; Pilocarpine; Status Epilepticus | 2018 |
Lacosamide exhibits neuroprotective effects in a rat model of Parkinson's disease.
Topics: Animals; Apomorphine; Disease Models, Animal; Dopamine; Dopaminergic Neurons; Lacosamide; Male; Malondialdehyde; Mice; Neuroprotective Agents; Parkinson Disease; Rats; Rats, Sprague-Dawley; Rotenone; Substantia Nigra; Tumor Necrosis Factor-alpha | 2023 |